Vascular Graft Impregnation with a Fosfomycin/Oritavancin Combination to Prevent Early Infection
<b>Background/Objectives:</b> Vascular graft infections (VGIs) represent a life-threatening complication, occurring in 0.2-6% of patients following aortic prosthetic placements. Historically, the primary focus for reducing VGIs has been on prevention. Currently, antimicrobial grafts are...
Saved in:
Main Authors: | Inês Cruz (Author), Stefano Di Bella (Author), Mario D'Oria (Author), Cristina Lagatolla (Author), M. Cristina L. Martins (Author), Cláudia Monteiro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant <i>Enterococcus faecium</i>
by: Cristina Lagatolla, et al.
Published: (2022) -
Use of a Silver-Impregnated Vascular Graft: Single-Center Experience
by: Jiri Molacek, et al.
Published: (2022) -
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review
by: Giammarco Baiardi, et al.
Published: (2023) -
Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <i>Klebsiella pneumoniae</i> Clinical Isolates
by: Venera Costantino, et al.
Published: (2024) -
Real-World Use of Oritavancin for the Treatment of Osteomyelitis
by: Patrick J. Scoble, et al.
Published: (2020)